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Abstract
Background: Interruption of mature axons activates a cascade of events in neuronal cell bodies
which leads to various outcomes from functional regeneration in the PNS to the failure of any
significant regeneration in the CNS. One factor which seems to play an important role in the
molecular programs after axotomy is the stearoyl Coenzyme A-desaturase-1 (SCD-1). This
enzyme is needed for the conversion of stearate into oleate. Beside its role in membrane synthesis,
oleate could act as a neurotrophic factor, involved in signal transduction pathways via activation of
protein kinases C.
Results: In situ hybridization and immunohistochemistry demonstrated a strong up-regulation of
SCD at mRNA and protein level in regenerating neurons of the rat facial nucleus whereas non-
regenerating Clarke's and Red nucleus neurons did not show an induction of this gene.
Conclusion: This differential expression points to a functionally significant role for the SCD-1 in
the process of regeneration.
Background
It is well known that damaged nerve fibers in the periph-
eral nervous system (PNS) have the capacity for complete
regeneration followed by the restoration of appropriate
synaptic connectivity and full functional recovery. How-
ever, damaged nerve fibers in the central nervous system
(CNS) only demonstrate an abortive sprouting response
without any functional regeneration. Up to now, little is
known about the molecular programs leading to these
fundamental differences. To gain insight into the molecu-
lar differences, we have compared the differentially regu-
lated genes of axotomized PNS neurons to those of
axotomized CNS neurons by differential display polymer-
ase chain reaction [1]. In the following study, we concen-
trate on one clone which corresponds to the 3' end of the
rat stearoyl-Coenzyme A desaturase-1 (SCD-1).
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The first mammalian cDNA of this enzyme was isolated in
1986 from rat liver [2]. Subsequently, two different SCD
isoforms (SCD-1 and SCD-2) were identified in mouse
3T3-L1 adipocytes [3,4]. Zheng et al. identified a third
SCD isoform (SCD-3) which is exclusively present in skin
[5] and most recently Miyazaki et al. identified a novel
heart-specific isoform (SCD4)[6].
Stearoyl-CoA desaturase is responsible for the rate limit-
ing step in the ?9-cis desaturation of a spectrum of meth-
ylene-interrupted fatty acyl-CoA substrates [7]. One of the
preferred substrates, stearoyl-CoA, is desaturated, result-
ing in oleoyl-CoA which is further converted into its cor-
responding fatty acid oleate. Beside its function as an
energy store in the form of triacylglycerides and its pres-
ence in biological cell membranes, several studies may
show an involvement of oleate in second messenger cas-
cades. Biochemical studies demonstrated the activation of
protein kinase C (PKC) by fatty acids and the subsequent
phosphorylation of regeneration-associated genes such as
the 43 kilodalton growth associated protein (GAP-43)
[8,9]. Recently, in vitro studies showed that oleate could
promote axonal outgrowth and neuronal clustering [10].
This induction of neuronal outgrowth was coupled with
the activation and accumulation of GAP-43 by a PKC
dependent mechanism [11].
Here, we describe the up-regulation of SCD-1 on the
mRNA and protein level in the regenerating facial and
hypoglossal nucleus. In contrast, SCD-1 could neither be
detected in axotomized Clarke's nucleus nor in Red
nucleus neurons.
Results
PNS injury
Radioactive ISH demonstrated a strong induction of SCD-
1 mRNA in neurons of the operated facial nucleus starting
at 3 days post operation (dpo), the earliest survival time
investigated. Figure 1 shows dark field (Fig. 1A) and bright
field (Fig. 1B) microscopy of the facial nucleus 3 dpo.
Numerous strongly labeled cells (white arrows) were visi-
ble which could be identified as motor neurons (black
arrows) by bright field microscopy (Fig. 1B). High power
magnification of axotomized facial nucleus neurons, as
shown in Figure 1C and 1D (7 dpo) verified the cell-spe-
cific SCD-1 expression.
In contrast, no significant SCD-1 mRNA could be detected
in non-axotomized neurons (black arrow) of the control
side 3 days p.o. (Fig. 1E,1F). Dark field analysis of these
cells (Fig. 1E) displayed a homogenous distribution of the
silver grains.
No specific signal could be obtained using the sense probe
at this or any other time point (Fig. 2A and 2B). Sham
operated and control animals displayed no induction of
SCD-1 mRNA in the facial nucleus (Fig. 2C and 2D).
To quantify the up-regulation of SCD-1 mRNA in axot-
omized facial nucleus neurons, we measured the signal
intensity of operated and non-operated neurons. To avoid
experiment-related differences in the intensity (e.g. due to
different exposure times), we analyzed all slides sepa-
rately. Table 1 shows the intensity of in situ hybridization
signal of the operated and non-operated side per survival
time. Two different distributions between the two groups
can be observed. First, repeated measure analysis yielded
significant differences with respect to the measured inten-
sity between operated and non-operated side (p < 0.0001)
with a clear up-regulation on the operated side. Second,
univariate analysis of operated and non-operated side
shows significant differences on the operated side with
respect to the measured intensity between the different
survival times (p = 0.0025) while no significant time-
effect could be proven on the non-operated side (p =
0.2234). This explains the existing significant interaction
between both sides, operated as well as non-operated, and
the different survival times (p = 0.0003), i.e. the measured
intensity changes over time in dependence on the respec-
tive side.
To illustrate the quantification data, means of intensity
were plotted against the survival time (Fig. 3). Up-regula-
tion of SCD-1 mRNA was first observed at the first time
point investigated (3 dpo) and was evident up to 42 days,
with a peak at 7 dpo. At 84 days after lesion, values had
returned to basal levels.
To prove that the up-regulation of SCD-1 mRNA is a gen-
eral response to axotomy of cranial motoneurons, we
used the hypoglossal nerve transection model as a second
PNS axotomy paradigm. In accordance with the results in
the facial nucleus model, SCD-1 mRNA was only detected
in axotomized hypoglossal neurons (Fig. 4A and 4B, right
side was transected). Again, no specific signal was visible
using the sense probes (data not shown).
To extend the results obtained by ISH to the protein level,
immunohistochemistry was performed using a polyclonal
antibody against the SCD isoforms. At 7 and 14 dpo a
strong up-regulation of the SCD protein in axotomized
facial nucleus neurons could be observed. Figure 5 illus-
trates this up-regulation within the operated facial
nucleus 7 dpo (Fig. 5A). High power magnification (Fig.
5C) demonstrated the cytoplasmic staining in every visi-
ble neuron (white arrows). In contrast, non-operated
facial nucleus neurons expressed only basal levels of SCD
protein (Fig. 5B and 5D). No signal could be detected by
omitting the primary antibody (Fig. 2E).BMC Neuroscience 2004, 5 http://www.biomedcentral.com/1471-2202/5/15
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SCD-1 specific radioactive in situ hybridization of facial nucleus neurons 3 and 7 dpo Figure 1
SCD-1 specific radioactive in situ hybridization of facial nucleus neurons 3 and 7 dpo. A and B show the operated side 3 dpo; 
numerous strongly labeled cells (arrows) are visible in dark filed microscopy (A) which were identified as neurons by bright 
field microscopy of the same area (B, arrows). High power magnification of axotomized facial nucleus neurons 7 dpo (C and D) 
verifies the neuron-specific SCD-1 expression due to their large diameter and characteristic thionine staining. No SCD-1 
mRNA induction could be identified in non-axotomized neurons (arrows) of the control side (E and F). Scale bars represent: 
200 µm (A, B, E and F), 50 µm (C and D).BMC Neuroscience 2004, 5 http://www.biomedcentral.com/1471-2202/5/15
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A and B show the operated facial nucleus 3 dpo Figure 2
A and B show the operated facial nucleus 3 dpo. Neither in bright field (A) nor in dark field (B) a specific in situ hybridization 
signal could be observed with the sense probe. C and D: In sham operated animals no SCD-1 up-regulation was observed using 
antisense probes. E shows the negative control of the immunohistochemistry, no signal could be detected by omitting the pri-
mary antibody. Scale bars represent: 50 µm.BMC Neuroscience 2004, 5 http://www.biomedcentral.com/1471-2202/5/15
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Table 1: Characteristics of operated and non-operated facial nucleus neurons per days post operation (dpo)
dpo Side N Mean SEM Minimum Maximum
3 operated 3 109.25 29.31 70.28 167.87
unoperated 3 63.41 14.13 47.19 91.56
7 operated 3 138.83 10.44 117.99 150.40
unoperated 3 76.96 6.82 69.36 90.57
14 operated 3 117.50 13.02 94.62 139.71
unoperated 3 59.83 5.56 49.51 68.56
28 operated 3 101.26 10.11 83.99 119.02
unoperated 3 63.15 6.64 50.18 72.13
42 operated 3 114.77 4.69 105.89 121.81
unoperated 3 75.08 3.17 69.45 80.44
84 operated 3 55.25 8.42 44.87 71.93
unoperated 3 52.11 8.29 40.25 68.07
Mean, SEM (standard error of the mean), Minimum and Maximum corresponds to the intensity of the in situ hybridization signal.
Quantification of the radioactive in situ hybridization signal shows the means of intensity ± SEM for the operated and non- operated side Figure 3
Quantification of the radioactive in situ hybridization signal shows the means of intensity ± SEM for the operated and non-
operated side. The operated side (continuos line) shows a slight drop at 28 days compared to 42 days, which is due to a 
shorter exposure time of these slides indicated by a lower constitutive expression of the non-operated side (dotted line).
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A and B show the hypoglossus model Figure 4
A and B show the hypoglossus model. SCD-1 mRNA could be only detected in axotomized neurons (arrows). C and D show 
axotomized Red nucleus neurons. No up-regulation of SCD-1 mRNA could be observed in dark (C) or in bright (D) field anal-
ysis. E and F show the Clarke's nucleus (dotted line); no up-regulation could be observed in the axotomized neurons. Arrows 
indicate the position of neurons in the corresponding bright field microscopy. Scale bars represent 200 µm (A, B) and 50 µm 
(C-F).BMC Neuroscience 2004, 5 http://www.biomedcentral.com/1471-2202/5/15
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CNS injury
By using ISH, SCD-1 mRNA could not be detected at any
time point (3, 7, 14 and 28 dpo) in axotomized as well as
in non-axotomized Clarke's and Red nucleus neurons
(Figs. 4C,4D,4E,4F).
Figure 4E and Fig. 4F show axotomized Clarke's nucleus
neurons 7 dpo. A specific hybridization signal could nei-
ther be detected in dark field (Fig. 4E) nor in bright field
(Fig. 4F) analysis. No specific signal was detected using
the sense probe (data not shown).
Immunohistochemistry against the SCD Figure 5
Immunohistochemistry against the SCD. A shows operated facial nucleus. Numerous immunoreactive cells are visible. In high 
power magnification (C), these cells could be identified as neurons (white arrows) due to their typical phenotype. B and D 
show the non-operated facial nucleus. No up-regulation of SCD could be identified. Scale bars represent 200 µm (A, B), 20 µm 
(C, D).BMC Neuroscience 2004, 5 http://www.biomedcentral.com/1471-2202/5/15
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Discussion
One major area of interest in spinal cord research is the
identification of regeneration-associated genes which are
responsible for the success or failure of functional
neuronal regeneration. Here, we describe the differential
expression pattern of SCD-1 in response to axotomy of
PNS and CNS neurons. SCD-1 mRNA and protein was
highly expressed in axotomized neurons of the regenerat-
ing facial and hypoglossal nucleus. This up-regulation was
already detectable at the earliest survival time studied (3
dpo), peaked at 7 to 14 dpo and was hardly visible at 84
dpo. In contrast, mRNA was not induced in non-regener-
ating axotomized Clarke's nucleus and Red nucleus neu-
rons, nor in non-axotomized control neurons.
This induction of SCD-1 is in line with other reports
which indicate that the terminal component of the fatty
acyl desaturase system (i.e. the stearoyl-CoA desaturase)
and not the preceding components (NADH cytochrome
b5 reductase and cytochrome b5) appears to be under reg-
ulatory control, as seen in developmental, hormonal or
metabolic processes [12,13].
Regarding the functional role of the up-regulation of SCD-
1 in regenerating motoneurons, two possible functions
can be discussed: 1. the production of phospholipids as
cell membrane components, 2. an involvement in signal
transduction pathways.
In the context of the first hypothesis, one can assume that
the induction of SCD-1 is necessary for the process of
regeneration of peripheral neurons as neuronal out-
growth is always coupled with the new synthesis of cell
membranes. This hypothesis is supported by the fact that
oleate, which is the major product of SCD-1, is a major
structural fatty acid in adult cell membranes, accounting
for up to 30% of the fatty acid content of the membrane.
Furthermore, it is one of the most abundant fatty acids in
developing neuronal growth cones and synaptosomes
[14,15]. Recently, in vitro studies could show that astro-
cyte-derived oleate was incorporated into newly formed
neuronal phospholipids in outgrowing neuronal cell cul-
tures [16].
Regarding the second hypothesis, experimental data point
to an involvement of the SCD-1 in signal transduction
pathways. Biochemical studies demonstrated the activa-
tion of PKC by free fatty acids [8,17]. In particular, oleate
and arachidonic acid were shown to activate the a, ß and
? subtypes of PKC with a subsequent phosphorylation of
the regeneration-associated protein GAP-43 [9]. In vivo
studies already demonstrated the involvement of GAP-43
in the process of facial nerve regeneration [18]. Recently,
in vitro studies could also show the activation of PKC by
oleate in neuronal cell cultures [16]. This activation led to
the accumulation and activation of GAP-43 in outgrowing
neurons, indicating that oleate could act as a neurotrophic
factor [11,19]. Additionally, Schaechtner and Benowitz
investigated the phosphorylation GAP-43 via PKC
activation in nerve terminal membranes. This activation
was stimulated by arachidonic acid as well as oleate [20].
These studies suggest a route whereby SCD-1 and its prod-
uct oleate can directly affect the process of regeneration.
The oleate could be produced by the neurons themselves
as shown in our model or derive from glial cells mainly
astrocytes as shown in previous investigations [10].
Conclusion
Taken together, we demonstrate for the first time an
involvement of the SCD-1 in the context of neuronal
regeneration. Beside an involvement in the production of
cell membrane components, the enzyme also play an
important role in signal transduction pathways via the
activation of PKC and subsequent phosphorylation of
downstream proteins which are known to be involved in
neuronal outgrowth.
Methods
Surgery
Adult Sprague Dawley rats were used for all experiments.
CNS lesions were performed by a lateral funiculotomy of
the spinal cord at spinal vertebra C2 or Th9 respectively.
For lesions of the PNS, the right facial nerve was
transected at the foramen stylomastoideum or the right
hypoglossal nerve was transected below the tendon of the
digastric muscle. Sham operated animals were used as
controls. Three rats were used for each survival time (3, 7,
14, 28, 42, and 84 days) and three unoperated animals
were used as further controls. All lesions were performed
as described earlier [1].
In situ hybridization and immunohistochemistry
The cDNA fragment of 350 bp containing the 3'end of the
SCD-1 mRNA (Ass. nr.: J02585) was subcloned into the p-
zero cloning vector (Invitrogen) according to the manu-
facturer's protocol. No significant homology to other
genes, including SCD2, SCD3 or SCD 4 was found. Tran-
scription and labeling reaction was carried out according
to the manufacturer's protocol (Roche Diagnostik) using
30 µCi of 35s-a SUTP (Amersham Pharmacia). In situ
hybridization (ISH) and immunohistochemistry were
performed as described earlier [1]. The polyclonal
antiserum against the C terminus of the SCD [21] was
used at a dilution of 1:1000.
Statistical analysis
For quantification of the in situ hybridization signal, the
quantification software KS300 (Zeiss; Göttingen) was
used. A minimal number of 3 sections per animal and at
least 3 animals per survival time were analyzed. FacialBMC Neuroscience 2004, 5 http://www.biomedcentral.com/1471-2202/5/15
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nucleus neurons were identified in bright field micros-
copy by their size and characteristic morphological pro-
file. The mean intensity of the signal caused by the
presence of the silver grains (belonging to the previously
identified neurons) was subsequently analyzed in dark
field analysis. This procedure allowed for the cell specific
measurement of the radioactive in situ hybridization
signal.
A mean intensity value for each animal was calculated for
the operated and non-operated side separately because of
different numbers of sections per animal. A generalized
linear model (GLM) with respect to repeated measure-
ments was then fitted to the data to investigate side to side
effects. The comparison of sides, operated and non-oper-
ated, was carried out using the F-test; p-values of less than
or equal to 0.05 were regarded as statistically significant.
All statistical analyses were performed using SAS V8.0
Software (SAS Institute Inc., Cary, NC, USA).
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